[Estimation of glomerular filtration rate using cystatin C].

Estimation du débit de filtration glomérulaire par la cystatine C.

Journal

Annales de biologie clinique
ISSN: 1950-6112
Titre abrégé: Ann Biol Clin (Paris)
Pays: France
ID NLM: 2984690R

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 22 1 2020
Statut: ppublish

Résumé

Blood concentration of cystatin C is independent of muscle mass and tubular secretion. It can be used, in the absence of a reference method, as an alternative marker to creatinine for the evaluation of renal function and the estimation of glomerular filtration rate (GFR). Both particle-enhanced immunonephelemetry (PENIA) or immunoturbidimetry (PETIA) methods are available to determine cystatin C. From an analytical point of view, it is recommended to use methods whose calibration is traceable to the reference material (ERM-DA471/IFCC) and to report an estimated GFR based on cystatin C. The main equations used are those developed in 2012 by the group "Chronic kidney disease epidemiology collaboration (CKD-EPI)" for adults and those published by Schwartz in 2012 for children. National and international recommendations suggest using a cystatin C-based GFR estimate as a confirmatory test in the clinical settings where the relationship between creatinine production and muscular mass impairs the clinical performance of creatinine. The indications retained by the working group were graded according to the level of recommendations. The essential indications are the estimation and/or the monitoring of renal function in children and adolescents due to rapid changes in muscle mass; in patients with impaired muscle mass and in patients with an alteration of tubular secretion of creatinine (essentially iatrogenic effects).

Identifiants

pubmed: 31418698
pii: abc.2019.1456
doi: 10.1684/abc.2019.1456
doi:

Substances chimiques

Biomarkers 0
Cystatin C 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

375-380

Auteurs

Anne-Sophie Bargnoux (AS)

Laboratoire de biochimie, PhyMedExp, Université de Montpellier, Inserm, CNRS, CHU de Montpellier, France.

Yann Barguil (Y)

Laboratoire de biochimie-toxicologie, Centre hospitalier territorial Gaston-Bourret, Nouméa, Nouvelle-Calédonie.

Etienne Cavalier (E)

Department of clinical chemistry, University of Liège (ULg CHU), Liège, Belgium.

Jean-Paul Cristol (JP)

Laboratoire de biochimie, PhyMedExp, Université de Montpellier, Inserm, CNRS, CHU de Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH